XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Equity | 9 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Equity | Equity Preferred Stock In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of December 31, 2024 and March 31, 2024, there were no shares of preferred stock issued and outstanding. Common Stock and Creation of Dual-Class Structure The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company’s board of directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company’s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of December 31, 2024, there were 133,448,777 shares of Class A common stock, and 54,135,272 shares of Class B common stock outstanding. Stock Repurchase Program Prior to March 31, 2024, the Company’s board of directors authorized various programs to repurchase up to $410 million of the Company’s Class A common stock. Under these programs, the Company repurchased and retired 16,480,514 shares of Class A common stock. All of these programs were completed as of April 2024. On May 1, 2024 the Company’s board of directors authorized a program to repurchase up to $500 million of the Company’s Class A common stock with no expiration date. As of December 31, 2024, the Company repurchased and retired 1,416,104 shares of Class A common stock under this program for an aggregate purchase price of $49.2 million and $450.8 million remained available and authorized for repurchase. All repurchases are subject to general business and market conditions and other investment opportunities and may be executed through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. Effective January 1, 2023, the Company’s share repurchases in excess of allowable share issuances are subject to a 1% excise tax as a result of the Inflation Reduction Act of 2022. As of March 31, 2024 the Company had accrued excise taxes of $1.5 million, all of which were paid during the third quarter of fiscal 2025. As of December 31, 2024, the Company had no accrued excise taxes. Common Stock Warrants In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News & World Report, L.P., or U.S. News. All shares under the warrant were exercised as of March 31, 2024 for an aggregate intrinsic value of $6.7 million. In October 2021, the Company issued a warrant to U.S. News (the “U.S. News Warrant”) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with U.S. News. The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant. The fair value of the warrant is recognized as expense in cost of revenue in the condensed consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the nine months ended December 31, 2024 and 2023, $4.0 million was recognized as stock-based compensation expense relating to the U.S. News Warrant. During the nine months ended December 31, 2024, 200,667 shares with an intrinsic value of $3.6 million were exercised under the warrant. The remaining 315,333 shares under the warrant were outstanding as of December 31, 2024. As of December 31, 2024, unamortized stock-based compensation expense related to the unvested warrants was $17.4 million, which is expected to be recognized over the remaining vesting period of 3.25 years. Equity Incentive Plans The Company maintains three equity incentive plans: the 2010 Equity Incentive Plan (the “2010 Plan”), the 2021 Stock Option and Incentive Plan (the “2021 Plan”), and the 2021 Employee Stock Purchase Plan (the “ESPP”). Upon IPO, the 2021 Plan became effective and the 2010 Plan was terminated. The 2010 Plan continues to govern the terms of outstanding awards that were granted prior to the termination of the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,044,582 options were exercised and 2,638,000 were outstanding as of December 31, 2024. The Company has shares of common stock reserved for issuance as follows (in thousands):
| December 31, 2024 |  |
Common stock warrants | 315 |  |  |
2010 Plan |  |  |
Options outstanding | 11,805 |  |  |
2021 Plan |  |  |
Awards outstanding | 4,060 |  |  |
Shares available for future grant | 40,431 |  |  |
2021 ESPP | 9,812 |  |  |
Options outstanding outside the plans | 2,638 |  |  |
Total | 69,061 |  |  |
Stock Options Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant. Stock option activities within the Plans as well as outside of the Plans were as follows:
| Number of Shares (in thousands) |  | Weighted-Average Exercise Price |  | Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (in thousands)
Balance, March 31, 2024 | 17,480 |  |  | $ | 4.60 |  |  | 5.72 |  | $ | 389,931 |
Options exercised | (2,941) |  |  | 3.90 |  |  |  |  |
Options forfeited or expired | (96) |  |  | 7.30 |  |  |  |  |
Balance, December 31, 2024 | 14,443 |  |  | 4.73 |  |  | 5.09 |  | 702,867 |
Vested and exercisable as of December 31, 2024 | 10,925 |  |  | 3.74 |  |  | 4.76 |  | 542,383 |
Vested and expected to vest as of December 31, 2024 | 14,443 |  |  | 4.73 |  |  | 5.09 |  | 702,867 |
The aggregate intrinsic value of options exercised during the nine months ended December 31, 2024 and 2023 was $100.5 million and $74.7 million, respectively. As of December 31, 2024, unamortized stock-based compensation expense related to unvested stock options was $12.9 million, which is expected to be recognized over a weighted-average period of 2.20 years. The Company has not granted any stock options since the first quarter of fiscal 2022. Restricted Stock Units (“RSUs”) RSUs granted by the Company generally vest over three or four years based on continued service. The following table summarizes RSU activity (in thousands, except per share information):
| Number of Shares |  | Weighted- Average Grant Date Fair Value
Unvested balance, March 31, 2024 | 2,093 |  |  | $ | 33.79 |
Granted | 2,905 |  |  | 27.66 |
Vested | (1,167) |  |  | 31.25 |
Forfeited | (162) |  |  | 27.12 |
Unvested balance, December 31, 2024 | 3,669 |  |  | 30.04 |
The total fair value of RSUs vested during the nine months ended December 31, 2024 and 2023 was $43.6 million and $15.4 million, respectively. As of December 31, 2024, total unrecognized stock-based compensation expense related to unvested RSUs was $101.4 million, which is expected to be recognized over a weighted-average period of 2.27 years. Performance-Based Restricted Stock Units (“PSUs”) During the nine months ended December 31, 2024, the Company granted 88,974 PSUs that are subject to both service-based and performance-based vesting conditions. During the nine months ended December 31, 2024, 66,654 PSUs vested. As of December 31, 2024, the unamortized stock-based compensation expense related to unvested PSUs was $4.4 million. The amount to be recognized will be based on the extent the performance metrics are achieved. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):
| Three Months Ended December 31, |  | Nine Months Ended December 31,
| 2024 |  | 2023 |  | 2024 |  | 2023
Cost of revenue | $ | 2,818 |  |  | $ | 2,466 |  |  | $ | 8,373 |  |  | $ | 7,205 |
Research and development | 4,471 |  |  | 3,080 |  |  | 14,602 |  |  | 8,874 |
Sales and marketing | 6,487 |  |  | 4,060 |  |  | 19,881 |  |  | 12,752 |
General and administrative | 5,592 |  |  | 2,165 |  |  | 11,470 |  |  | 6,742 |
Restructuring | — |  |  | — |  |  | — |  |  | 3,646 |
Total stock-based compensation expense | $ | 19,368 |  |  | $ | 11,771 |  |  | $ | 54,326 |  |  | $ | 39,219 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration